1 company and 4 research reports found for "Aastrom Biosciences"
- Aastrom Biosciences
Aastrom Biosciences uses autologous cell therapy, ixmyelocel-T, to process and inject the patientís ...
No sector reports have been found.
Aastrom BiosciencesPharmaceutical & healthcare | 23/05/2013
Aastrom’s Q1 results show its consolidation onto affordable clinical studies and a determination to achieve a solid cash basis. The focus is on ...
Aastrom BiosciencesPharmaceutical & healthcare | 02/04/2013
The review led by new CEO, Mr Colangelo, concluded that the REVIVE chronic limb ischaemia Phase III study will take too long to recruit and is beyond ...
Aastrom BiosciencesPharmaceutical & healthcare | 23/03/2012
Following the presentation of full Phase II RESTORE critical limb ischaemia (CLI) data and a $40m funding, Aastrom will enter a quiet news period. RES...